Immobilisation of vaccines onto micro-crystals for enhanced thermal stability

International Journal of Pharmaceutics

Volumn 296, Issue 1-2, 2005, Pages 117-121

  Murdan, S ^a   Somavarapu, S ^a   Ross, Alistair C ^b,c   Alpar, H O ^a   Parker, M C ^c  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c XstalBio Limited   (United Kingdom)

Author keywords

Heat; PCMC; Stability; Thermal instability; Vaccine

Indexed keywords

DIPHTHERIA VACCINE; GLUTAMINE; IMMUNOGLOBULIN G;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CRYSTALLIZATION; DESICCATION; DRUG STABILITY; IMMOBILIZATION; INCUBATION TIME; MOUSE; NONHUMAN; POWDER; PRIORITY JOURNAL; SURFACE PROPERTY; TEMPERATURE; THERMOSTABILITY;

ANIMALS; CRYSTALLIZATION; DRUG STABILITY; FEMALE; HEAT; MICE; MICE, INBRED BALB C; MICROSPHERES; VACCINES;

EID: 18844390429     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2005.02.022     Document Type: Article

References (18)

1. S.C. Arya Human immunization in developing-countries - practical and theoretical problems and prospects Vaccine 12 1994 1423 1435
2. K.N. Bell, C.J.R. Hogue, C. Manning, and A.P. Kendal Risk factors for improper vaccine storage and handling in private provider offices Pediatrics 107 2001 (art. no. e100)
3. V.W. Bramwell, S. Somavarapu, I. Outschoorn, and H.O. Alpar Adjuvant action of melittin following intranasal immunisation with tetanus and diphtheria toxoids J. Drug Target 11 2004 525 530
4. D.T. Brandau, L.S. Jones, C.M. Wiethoff, J. Rexroad, and C.R. Middaugh Thermal stability of vaccines J. Pharm. Sci. 952 2003 218-231
5. G. Lancz, and J. Sample Thermal-pH inactivation of herpes simplex virus: interdependence of the medium composition and the pH on the rate of inactivation Arch. Virol. 84 1985 141 146
6. Y.F. Maa, M. Ameri, C. Shu, L.G. Payne, and D.X. Chen Influenza vaccine powder formulation development: spray-freeze-drying and stability evaluation J. Pharm. Sci. 93 2004 1912 1923
7. 2-stabilised oral poliovaccine JAMA 185 1963 406 408
8. J.B. Milstien, S.M. Lemon, and P.F. Wright Development of a more thermostable poliovirus vaccine J. Infect. Dis. 175 1997 S247 S253
9. Parker, M.C., Partridge, J., Ross, A.C., Moore, B.D., 2003. Protein-coated micro-crystals: particle engineering for the advanced delivery of biomolecules. Abstr. Pap. Am. Chem. Soc. 226, 475-PMSE.
10. A.C. Ross, J. Partridge, M.V. Flores, B.D. Moore, M.C. Parker, and H.N.E. Stevens Peptide and protein drug delivery using protein coated micro-crystals Proc. 29th Int. Symp. Control. Rel. Bioact. Mater 2002 53
11. A.C. Ross, J. Partridge, J. Vos, A. Ganesan, H.N.E. Stevens, B.D. Moore, and M.C. Parker Engineering the morphology of protein coated amino acid crystals J. Pharm. Pharmacol. 56 2004 S45
12. R.J. Salo, and D.O. Cliver Effect of pH, salts and temperature on the infectivity and physical integrity of enteroviruses Arch. Virol. 52 1976 269 282
13. S. Setia, H. Mainzer, M.L. Washington, G. Coil, R. Synder, and B.G. Weniger Frequency and causes of vaccine wastage Vaccine 20 2002 1148 1156
14. D.W. Stainer, and F.E. Hart The stability of bacterial vaccines at elevated temperatures Dev. Biol. Stand. 41 1978 249 253
15. J.D. van Ramshorst, and A.L. van Wezel The stability of the components of quadruple (DTP polio) vaccines Proceedings of the Symposium on Stability and Effectiveness of Measles, Poliomyelitis and Pertussis Vaccines The Yugoslav Academy of Sciences and Arts, Zagreb 1976 pp. 189-195
16. WHO, UNAIDA, World Bank, UNESCO, and UNFPA Health: a key to prosperity Success Stories in Developing Countries 2000 World Health Organisation Geneva
17. E.E. Worrall, J.K. Litamoi, B.M. Seck, and G. Ayelet Xerovac: an ultra rapid method for the dehydration and preservation of live attenuated Rinderpest and Peste des Petits ruminants vaccines Vaccine 19 2000 834 839
18. 2O) Vaccine 13 1995 1058 1063